Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s Next Step to Real-World Evidence: Prove That Real-World Studies Can Match Known RCT Results

This article was originally published in RPM Report

Executive Summary

Industry is eager to develop approval pathways that rely on “real world” evidence from insurance claims and electronic health records. FDA, however, thinks the next step needs to be develop and validate the methodology.

Advertisement

Related Content

Real-World Data Could Get Boost From Trial Replication Project

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS079910

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel